ArticleJournal of Cancer2025

Integrative Multi-Omics Analysis and Experimental Validation Identify SPOP as a Prognostic Biomarker and Immune Regulator in Lung Adenocarcinoma.

Yu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.